Josep Bassaganya-Riera
Amministratore Delegato presso Biotherapeutics, Inc.
Posizioni attive di Josep Bassaganya-Riera
Società | Posizione | Inizio | Fine |
---|---|---|---|
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Amministratore Delegato | - | - |
Presidente | - | - | |
Fondatore | 01/01/2008 | - | |
Presidente | - | - | |
Nutritional Immunology & Molecular Medicine Laboratory | Direttore/Membro del Consiglio | 01/07/2002 | - |
Amministratore Delegato | 01/07/2002 | - | |
Fondatore | 01/07/2002 | - | |
Presidente | 01/07/2002 | - |
Storia della carriera di Josep Bassaganya-Riera
Precedenti posizioni note di Josep Bassaganya-Riera
Società | Posizione | Inizio | Fine |
---|---|---|---|
LANDOS BIOPHARMA, INC. | Amministratore Delegato | 01/01/2017 | 06/11/2021 |
Presidente | 01/01/2017 | 06/11/2021 | |
Fondatore | 01/01/2017 | 06/11/2021 | |
Presidente | 01/01/2017 | 06/11/2021 | |
Virginia Polytechnic Institute & State University | Corporate Officer/Principal | - | - |
Formazione di Josep Bassaganya-Riera
Iowa State University | Doctorate Degree |
Universitat Autònoma de Barcelona | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Spagna | 2 |
Posizioni
Chief Executive Officer | 3 |
Founder | 3 |
President | 3 |
Settori
Consumer Services | 4 |
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
LANDOS BIOPHARMA, INC. | Health Technology |
Aziende private | 2 |
---|---|
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Health Technology |
Nutritional Immunology & Molecular Medicine Laboratory |